- Home
- OMC vs BAX Comparison
OMC vs BAX Comparison
Compare OMC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMC
- BAX
- Stock Information
- Founded
- OMC 1944
- BAX 1931
- Country
- OMC United States
- BAX United States
- Employees
- OMC N/A
- BAX 38000
- Industry
- OMC Advertising
- BAX Medical/Dental Instruments
- Sector
- OMC Consumer Discretionary
- BAX Health Care
- Exchange
- OMC Nasdaq
- BAX Nasdaq
- Market Cap
- OMC 14.0B
- BAX 11.6B
- IPO Year
- OMC N/A
- BAX N/A
- Fundamental
- Price
- OMC $72.93
- BAX $23.68
- Analyst Decision
- OMC Buy
- BAX Hold
- Analyst Count
- OMC 7
- BAX 9
- Target Price
- OMC $94.43
- BAX $32.00
- AVG Volume (30 Days)
- OMC 4.2M
- BAX 9.8M
- Earning Date
- OMC 07-15-2025
- BAX 07-31-2025
- Dividend Yield
- OMC 3.84%
- BAX 2.87%
- EPS Growth
- OMC N/A
- BAX N/A
- EPS
- OMC 7.00
- BAX N/A
- Revenue
- OMC $15,910,800,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- OMC $4.74
- BAX $8.05
- Revenue Next Year
- OMC $10.28
- BAX $4.19
- P/E Ratio
- OMC $10.43
- BAX N/A
- Revenue Growth
- OMC 5.21
- BAX N/A
- 52 Week Low
- OMC $68.37
- BAX $21.33
- 52 Week High
- OMC $107.00
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- OMC 49.43
- BAX 34.76
- Support Level
- OMC $70.61
- BAX $22.29
- Resistance Level
- OMC $73.89
- BAX $23.23
- Average True Range (ATR)
- OMC 1.94
- BAX 0.95
- MACD
- OMC -0.16
- BAX -0.34
- Stochastic Oscillator
- OMC 26.70
- BAX 29.30
About OMC Omnicom Group Inc.
Omnicom is a holding company that owns several advertising agencies and related firms. It provides traditional and digital advertising services that include creative design, market research, data analytics, and ad placement. In addition, Omnicom provides outsourced public relations and other communications services. The firm operates globally, providing services in more than 70 countries; it generates more than half of its revenue in North America and nearly 30% in Europe. The firm announced plans to merge with Interpublic Group in December 2024, pending regulatory approval.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.